Former FDA Commissioner Dr Marty Makary stated in 2025 that the agency was investigating reports of children dying after Covid-19 vaccination. His comments during a CNN interview raised questions about how such cases were handled internally.

In September 2025, Dr. Marty Makary, then head of the US Food and Drug Administration, confirmed during a television interview that the agency was actively investigating reports of children who had died after receiving the Covid-19 vaccine. He noted that officials were meticulously examining these reports to understand any possible causal links or contributing factors, emphasizing the seriousness with which the FDA approached such critical public health concerns. The agency's commitment was to ensure the utmost transparency and scientific rigor in its assessments.

Makary's remarks came amid escalating claims of internal disagreements within the FDA regarding the appropriate strategy for addressing and communicating these sensitive cases to the public. Critics and some internal sources argued that the agency had not been sufficiently open or proactive in sharing preliminary findings, leading to public anxiety and speculation. This situation underscored the complex challenge of balancing ongoing investigations with the public's right to timely information about vaccine safety, especially concerning vulnerable populations.

The statements sparked renewed and intense discussion across medical communities, public health organizations, and among parents concerning vaccine safety monitoring for young people. They also significantly highlighted the persistent need for clear, consistent, and timely information from health authorities when serious concerns or adverse events arise, reinforcing the importance of public trust in official health guidance. The FDA's ongoing investigation promised a thorough review to inform future public health policies.

Original Author: Maryanne Demasi | Source: Brownstone Institute